DUKE Robotics Corp.
For the period ended May 20, 2026. Filed May 20, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 20, 2026 · Filed May 20, 2026
Use the contents to explore the available documents and sections.
DUKR$3.01+4.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(USD in thousands, except share and per share data)
| March 31, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents | $475 | $750 |
| Restricted cash | 35 | — |
| Trade receivables | 16 | 41 |
| Other current assets | 287 | 116 |
| Total current assets | 813 | 907 |
| Operating lease right-of-use asset and lease deposit | 114 | 127 |
| Property and equipment, net | 190 | 215 |
| Total assets | $1,117 | $1,249 |
| Liabilities and Shareholders’ Equity | ||
| Current Liabilities | ||
| Accounts payable | $206 | $129 |
| Operating lease liability | 73 | 72 |
| Other liabilities | 324 | 366 |
| Stock purchase warrants liability | 708 | 189 |
| Total current liabilities | 1,311 | 756 |
| Related parties loans | 332 | 330 |
| Operating lease liability | 47 | 63 |
| Total liabilities | 1,690 | 1,149 |
| Stockholders’ Equity | ||
| Common stock, $0.0001 par value; 350,000,000 shares authorized; 2,260,383 and 2,177,045 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | * | * |
| Additional paid-in capital | 16,693 | 12,505 |
| Foreign currency translation adjustments | (1) | (2) |
| Accumulated deficit | (17,265) | (12,403) |
| Total stockholders’ equity (deficit) | (573) | 100 |
| Total liabilities and stockholders’ equity | $1,117 | $1,249 |
| (*) | Represents an amount less than $1 thousand. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.